Tyngsboro, MA, United States of America

Sucharita Roy

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Acton, MA (US) (2022)
  • Tyngsboro, MA (US) (2013 - 2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations by Sucharita Roy: Pioneering FcRn Antibodies

Introduction

Sucharita Roy, an esteemed inventor based in Tyngsboro, MA, has made significant contributions to the field of immunology through her innovative research. With a portfolio of 11 patents, her work focuses primarily on the development of FcRn antibodies and their applications in treating various immunological diseases.

Latest Patents

Among her latest patents, Sucharita has developed antibodies that exhibit a high binding affinity to the human neonatal Fc receptor (FcRn). These anti-FcRn antibodies serve several therapeutic purposes, including promoting the clearance of autoantibodies, suppressing antigen presentation, and blocking immune responses, particularly those activated by immune complexes. Notably, her inventions extend their utility to addressing immunological conditions, such as autoimmune diseases. Additionally, these antibodies have implications for pregnant subjects by decreasing pathogenic antibody transport across the placenta, enhancing pathogenic antibody catabolism, and treating antibody-mediated enhancement of viral diseases in fetuses or neonates.

Career Highlights

Sucharita currently serves as a vital member of the team at Momenta Pharmaceuticals, Inc., where her innovative spirit and expertise in antibody research contribute to the company's mission of advancing therapeutic solutions. Her contributions have been instrumental in pushing the boundaries of what is achievable in immunological therapies.

Collaborations

Throughout her career, Sucharita has collaborated with prominent colleagues, including Takashi Kei Kishimoto and Mallikarjun Sundaram. These partnerships have facilitated a synergistic approach to research and development, ultimately leading to the successful realization of groundbreaking therapeutic inventions.

Conclusion

Sucharita Roy's dedication to her craft and her innovative work have positioned her as a leading figure in the development of FcRn antibodies. With her extensive patent portfolio and collaborative efforts, she continues to influence the field of immunology positively, paving the way for future advancements in treating immunological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…